Piramal Critical Care, a part of Piramal Pharma, and Ireland-based BrePco Biopharma have received marketing approval from the ...
US Food and Drug Administration (US FDA) for its ANDA Norepinephrine Bitartrate Injection USP, 4 mg/4 mL (1 mg/mL) ...
Piramal Critical Care has reserved commercialisation rights for the EU, UK, and Norway and will look after Neoatricon in ...
Piramal Critical Care and BrePco Biopharma have secured UK approval for Neoatricon, a medication for low blood pressure and ...
BrePco Biopharma Limited today announced that the UK Medicines and Healthcare products Regulatory Agency issued a grant of a ...
Developed by Ireland-based BrePco Biopharma, Neoatricon is the first paediatric-strength dopamine hydrochloride infusion for ...
4d
DelveInsight's "LUXTURNA Market Size, Forecast, and Market Insight Report" highlights the details around LUXTURNA, a one-time ...
Glenmark's Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose Vials can be expected to have the same therapeutic effect as the listed drug product upon which the Agency relied as the ...
6 gm/30 mL (200 mg/mL) single-dose vials. Glenmark’s acetylcysteine injection, 6 gm/30 mL (200 mg/mL) single-dose vials can be expected to have the same therapeutic effect as the listed drug product ...
After approval by the FDA, AVT03 is expected to be supplied in a single-dose prefilled syringe containing 60 mg in a 1 ml ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback